Urup, T., Hedegaard Dahlrot, R., Grunnet, K., Jarle Christensen, I., Regner Michaelsen, S., Toft, A., … Lassen, U. (2016). Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan. Acta Oncologica, 55(4), 418–422. https://doi.org/10.3109/0284186X.2015.1114679